Sort
48,018 grants matching “immunotherapy”
Signal and Transcription Factor Network interactions in Head and Neck Cancer
$648,446Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2020 · DC
Defining the role of cytomegalovirus in glioblastoma therapies
$648,427Sean Edward Lawler · Brown University · R01 · FY2023 · CA
Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.
$648,380Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
Targeting Latency Switch in EBV+ Lymphomas
$648,353Lisa Giulino Roth · Weill Medical Coll Of Cornell Univ · R37 · FY2023 · CA
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells
$648,309Traci Leigh Hilton · Ubivac, Llc · R44 · FY2012 · CA
Targeting Alloreactivity for Leukemia Eradication
$648,309Stanley R Riddell · Fred Hutchinson Cancer Research Center · P01 · FY2009 · CA
Targeting polo-like kinase 1 (PLK1) for treatment of small cell lung cancer
$648,269Taofeek K Owonikoko · University Of Maryland Baltimore · R01 · FY2025 · CA
Immunological consequences of LINE-1 expression in cancer
$648,232Katherine B Chiappinelli · George Washington University · R01 · FY2024 · CA
Tissue Processing-Sequencing Facility
$648,227Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
HIFU-immunotherapy in pancreatic cancer
$648,066Katherine W Ferrara · Stanford University · R01 · FY2020 · CA
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB
$648,004Jyothi Rengarajan · Emory University · R01 · FY2021 · AI
Characterizing the nuclear pore complex-T cell receptor connection
$647,737Maximiliano A Dangelo · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · AI
Molecular Imaging and Targeted Therapy of HER2-Positive Breast Cancers
$647,703Jacek Capala · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
ALL immunobiology and the bone marrow niche
$647,674Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
TNF-alpha-"armed" TCR vectors to enhance adoptive cell therapy for solid tumors
$647,632Theodore Scott Nowicki · University Of California Los Angeles · R37 · FY2025 · CA
Therapy Resistance Mechanisms for Cancer
$647,591Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
CPF1-GUIDED IN VIVO GENOMEWIDE SCREEN FOR DISCOVERY OF IMMUNOTHERAPY IN PANCREATIC CANCER
$647,457The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2020 · Department of the Army
Multi-omic analysis of Myc-driven splicing for prostate cancer therapeutic development
$647,398Owen N Witte · University Of California Los Angeles · R01 · FY2020 · CA
Multi-omic analysis of Myc-driven splicing for prostate cancer therapeutic development
$647,398Owen N Witte · University Of California Los Angeles · R01 · FY2021 · CA
Regulatory T cells in cancer therapy
$647,392Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
CTL-killing capacity and cancer stiffness in cancer immunity and therapy
$647,366Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Regulatory T cells in cancer therapy
$647,349Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
CTL-killing capacity and cancer stiffness in cancer immunity and therapy
$647,331Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Modulating the PD-1/PD-L1 checkpoint to promote antitumor activity of HER2 CAR T cells in patients with sarcoma
$647,322Meenakshi G Hegde · Baylor College Of Medicine · R01 · FY2025 · CA
Naive T cells in Cancer Immune Evasion and Immunotherapy
$647,249Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2021 · CA